Testing a new flu vaccine with or without adjuvant
Part of Infections, Lungs & breathing clinical trials.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 50 years old and in good health
- You have gotten a flu shot at least once between the 2020-2021 and 2024-2025 flu seasons
- You are willing to not get the standard 2025-2026 flu shot while in the study
- You can commit to clinic visits over about 68 weeks (about 16 months)
- Your body mass index (BMI) is 35 or less
- You have no major medical conditions (like uncontrolled asthma, diabetes, or immune disorders)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of flu vaccine that targets a part of the virus that doesn't change much (the stem). It is given with or without a special booster, and researchers want to see if it provides broader protection against different flu strains.
This trial tests an experimental mRNA flu vaccine in healthy adults ages 18 to 59. Researchers want to see if it is safe and helps the body build protection against the flu.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.
Hear when a new Influenza Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.